Region — International. Neutral scientific reference — not offered for sale here.
Cart · 0
Set region
Explore  /  Salicylic Acid
Research reference — not for sale

Salicylic Acid

A
lead outcome
Exfoliation & refined-pore appearance (the…
grades vary by outcome ↓
Small molecule (non-peptide)
also called — INCI: Salicylic Acid · 2-hydroxybenzoic acid · o-hydroxybenzoic acid · BHA (beta hydroxy acid) · C7H6O3
skin appearance (cosmetic)exfoliation (appearance)oil-control (appearance)
In brief

Salicylic acid is the one everyday beta-hydroxy acid (BHA), and its whole identity rests on a single property: it is oil-soluble, so unlike the water-soluble AHAs it dissolves through sebum and exfoliates inside the oily pore. That makes it the go-to exfoliant for oily, congested, blemish-prone-looking skin — softening the look of blackheads and refining the appearance of pores — and its larger molecule often makes it gentler on the surface than glycolic. One honest boundary defines this entry: in the US, salicylic acid at 0.5–2% is an FDA-recognised OTC acne-DRUG active, and it has anti-inflammatory and mildly antibacterial mechanisms in the reference literature. That is a regulatory drug status and a reference-layer mechanism, reported here as context — not cosmetic claims. So this card grades the cosmetic exfoliation and clearer-look use only; "treats acne", "anti-inflammatory", "antibacterial" and "unclogs pores" are firewalled out. It is a distinct substance from Betaine Salicylate and Willow Bark.

Legal standing, by region
European Union
Lawful cosmetic ingredient (restricted)

Salicylic Acid (INCI) is a lawful cosmetic ingredient in the EU (Regulation (EC) 1223/2009), CosIng-listed, with concentration limits and use conditions (e.g. up to ~2% in leave-on face products) and a restriction on use in products for children under 3 (other than shampoo). A distinct substance — Betaine Salicylate, Willow Bark (Salix) and salicylates are NOT synonyms.

United States
Lawful cosmetic ingredient; separately an OTC acne-drug active

As a cosmetic, salicylic acid is lawful. SEPARATELY, in the US it is an FDA-recognised OTC acne-drug active at 0.5–2% (21 CFR 333) — a product making acne-treatment claims is regulated as an OTC drug, not a cosmetic. Higher-strength peels (typically 15–30%) belong in a dermatologist's office or medspa. That regulatory status is reported as context; it is NOT a cosmetic claim Vallydia makes, and this entry grades only the cosmetic appearance use.

Evidence, by outcome
How we grade →

An honest grade per outcome — drawn from the evidence, not any catalogue. Hype and undemonstrated marketing claims grade low.

OutcomeEvidence base · effectGrade
Exfoliation & refined-pore appearance (the oil-soluble BHA)
This is the appearance of exfoliation and refined pores. It is COSMETIC and is NOT the same as salicylic acid's separate OTC acne-drug status (see the D row and legal note) — regulatory recognition is not a Vallydia cosmetic grade. Ease in; it can dry or irritate.
Salicylic acid is the one common beta-hydroxy acid, and its defining property is oil solubility: it dissolves through sebum and works inside the oily pore, where the water-soluble AHAs cannot reach. As a keratolytic it loosens dead cells at the surface and within the follicle, so the look of blackheads, congestion and rough texture softens. This pore-level exfoliation is its strongest, best-evidenced cosmetic use. · Smoother-looking texture and the appearance of clearer, more refined, less-congested pores — the exfoliant of choice for oily, blemish-prone-looking skin
A
Oily, congested-look control (appearance)
Appearance of oil control and clarity, not a treatment. Persistent or inflamed acne is a dermatologist's remit — the "treats acne" story stays out of the cosmetic claims (D row).
Because it clears the oil and debris that make pores look enlarged and skin look shiny, salicylic acid helps oily-looking, congested skin appear clearer and less greasy over time. Its larger molecule makes it, surprisingly, often gentler on the surface than glycolic — well tolerated by many oily and even some sensitive complexions. · Less shiny-, clearer-looking skin; helps reduce the look of excess oil and congestion
B
"Treats acne / anti-inflammatory / antibacterial / unclogs pores / heals breakouts"
In the US salicylic acid at 0.5–2% is an FDA-recognised OTC ACNE-DRUG active (21 CFR 333), and it has anti-inflammatory and mildly antibacterial mechanisms in the reference literature. Those are drug framings, not cosmetic claims: "treats acne", "anti-inflammatory", "antibacterial", "kills bacteria", "unclogs pores" and "heals breakouts" are firewalled out. The mechanisms are described in the body; the cosmetic claim stays at the level of appearance.
Outside cosmetic scope
D
Disclosure

Vallydia sells its own cosmetic serums, and some ingredients graded here belong to the same categories as those products. Grades are drawn from the published evidence by the method we publish, and applied to our own ingredients on the same terms — our copper-peptide serum is graded no more kindly than the peptides it competes with. We disclose the interest so you can weigh it.

Trade names shown here (for example Matrixyl, Argireline, Syn-Ake) are the property of their respective owners and are used only to identify the ingredient under discussion. Their appearance implies no affiliation with, or endorsement by, the proprietor.

Evidence changes

Get notified if this changes

We track new research and update these grades as the evidence moves. Leave your email and we'll tell you if the evidence for Salicylic Acid changes - nothing else.

One ingredient, one purpose. No marketing, no sharing. Unsubscribe anytime. See our privacy policy.

Cosmetic claims boundary
✓ Allowed (appearance / feel)
  • helps the look of clearer, less-congested skin
  • smooths the look of texture and refines the appearance of pores
  • helps reduce the look of excess oil and shine
  • a leave-on exfoliant suited to oily, blemish-prone-looking skin
✕ Not allowed (medicinal)
  • treats acne
  • anti-inflammatory
  • antibacterial
  • kills bacteria
  • unclogs pores
  • heals breakouts
  • skin protectant

The medicinal-sounding science stays in the reference section; product copy speaks only to appearance/feel (Reg 655/2013). Different fields, never merged.

Identity

Salicylic acid is the one beta-hydroxy acid (BHA) you'll actually meet on a label. Its whole character comes from a single fact: it is oil-soluble. The alpha-hydroxy acids (glycolic, lactic, mandelic) are water-soluble and work on the skin's surface; salicylic acid dissolves through sebum and reaches inside the oily pore. That is why it is the exfoliant paired, again and again, with oily, congested, blemish-prone-looking skin.

It is a distinct substance. Betaine Salicylate, Willow Bark (Salix), and other salicylates are not synonyms of salicylic acid — they are different materials with their own labels and profiles.

Development & history

  • Salicylic acid sits on the cosmetic/OTC-drug boundary: in the US, at 0.5–2%, it is an FDA-recognised OTC acne-drug active, while at cosmetic exfoliating levels it is used for texture and the look of pores.
  • Its larger molecule means that, despite reaching deep into pores, it is often gentler on the surface than the smaller, faster glycolic acid.
  • Higher-strength salicylic peels (roughly 15–30%) exist but belong in a dermatologist's office or medspa — not the bathroom shelf.

Mechanism (as proposed)

Salicylic acid works as an oil-soluble keratolytic: it loosens the bonds between dead cells both at the surface and within the follicle lining, and because it is lipophilic it can do this inside a sebum-filled pore where a water-soluble acid never penetrates. The visible result is the softening of blackheads and congestion and the appearance of smoother, clearer, more refined pores.

In the reference literature it also has anti-inflammatory and mildly antibacterial activity, which is why it is a clinical go-to for acne — but those are the mechanisms behind its OTC acne-drug status. In this cosmetic entry they are reported, not claimed: the claims stay at the level of appearance — the look of clearer, less-congested, less-shiny skin — while "treats acne", "anti-inflammatory", "antibacterial" and "unclogs pores" stay out. Salicylic acid increases sun sensitivity less than the AHAs, but daily sunscreen remains sensible; persistent or inflamed acne is a matter for a doctor, not a stronger bottle.

Chemical identifiers

Cross-reference identifiers for the authoritative external databases — not a recipe, and nothing about how to use it.

PubChem CID338
InChIKeyYGSDEFSMJLZEOE-UHFFFAOYSA-N
SMILESC1=CC=C(C(=C1)C(=O)O)O

via PubChem exact-name match (salicylic acid, CID 338). · high confidence

Sources — 2 cited
01Arif T. Salicylic acid as a peeling agent: a comprehensive review. Clin Cosmet Investig Dermatol. 2015; 8:455-461.
02Zander E, Weisman S. Treatment of acne vulgaris with salicylic acid pads. Clin Ther. 1992; 14(2):247-253.
Updated 2026-07-25

Grades reflect the published evidence, not our interest. No dosing, reconstitution, or administration is published for research compounds — that restraint is deliberate.

Related compounds
Mandelic AcidB
Small molecule (non-peptide)
Niacinamide (Vitamin B3)A
Small molecule (non-peptide)
Colloidal OatmealB
Blend / combination
Explore by goal
Skin & aesthetic
Vallydia

A neutral reference and a lawful-lane shop. Information for those who seek it — never promotion.

RegionInternational
ExploreRegisterThe Register — full indexCategoriesTrust & COAHow we gradeOpen data
ShopCosmetic peptidesJournalQuizzes
TermsPrivacyCookiesReturnsShippingImprint

This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia.